Oncological Urology, in particular diagnosis and treatment of prostate cancer, is certainly undergoing a phase which could be literally defined “epochal”. From biopsies, being carried out “blindy” until not long ago, without appropriate image guidance, to complete organ removal, more focused diagnostic and therapeutic approaches are being gradually introduced, based on functional image guidance and on technological state-of-the-art.

Multidisciplinary competences in medical physics, biomedical engineering and informatics, acquired during over 30 years of direct experience on the field, make Tema Sinergie a reference point for operators within Oncological Urology, who are more and more aware and interested in technological innovation and clinical results obtained thereof.
Tema Sinergie is therefore profoundly proud to introduce and supply revolutionary success solutions for prostate cancer diagnosis and treatment, by means of approaches in pursuit of mini-invasiveness and of the significant improvement in patient’s life quality.

C.F., P.IVA, VATn. IT00970310397
Business Register of Ravenna n. 00970310397  |  R.E.A. 111877
RAEE IT08020000002755
Capital Stock € 2.000.000,00 paid-up